Monopar Therapeutics
MNPR
#7632
Rank
A$0.54 B
Marketcap
A$81.72
Share price
-4.29%
Change (1 day)
5.32%
Change (1 year)

Market capitalization of Monopar Therapeutics (MNPR)

Market cap: A$0.54 Billion

As of February 2026 Monopar Therapeutics has a market cap of A$0.54 Billion. This makes Monopar Therapeutics the world's 7632th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Monopar Therapeutics from 2019 to 2026

End of year Market Cap

Year Marketcap Change
2026A$0.54 B-20.41%
2025A$0.68 B185.28%
2024A$0.24 B3139.86%
2023A$7.42 M-83.5%
2022A$44.99 M-19.33%
2021A$55.78 M-38.81%
2020A$91.15 M-63.69%
2019A$0.25 B

End of Day market cap according to different sources

On Feb 5th, 2026 the market cap of Monopar Therapeutics was reported to be:

A$0.54 Billion
by Nasdaq info icon info icon
A$0.54 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
A$1.39 B 155.19%๐Ÿ‡บ๐Ÿ‡ธ USA